Director/PDMR Shareholding, Issue of Equity & TVR
Source: RNS
Nexteq plc
("Nexteq" or the "Group")
Director/PDMR Shareholding
and
Total Voting Rights
Nexteq (AIM: NXQ), a leading technology solutions provider to customers in selected industrial markets, announces that it has applied to the London Stock Exchange for 25,000 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") to be admitted to trading on AIM ("Admission"). The new Ordinary Shares are being issued subsequent to the exercise of options over Ordinary Shares by Johan Olivier, Group Chief Financial Officer, at an exercise price of 0.1 pence per Ordinary Share. Subsequent to his exercise of options, Johan Olivier has sold 11,000 Ordinary Shares at a price of 151 pence per Ordinary Share to cover his associated tax costs. His residual holding in the Company following these transactions is 14,000 Ordinary Shares, representing 0.02 per cent. of the Company's issued share capital.
Total Voting Rights
It is expected that Admission will become effective and trading will commence in the new Ordinary Shares at 8.00 a.m. on 18 March 2024. On Admission the Company's issued share capital will comprise 66,539,060 Ordinary Shares. The Company holds no Ordinary Shares in treasury. Accordingly, the figure of 66,539,060 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
|
Nexteq plc Jon Jayal, Chief Executive Officer Johan Olivier, Chief Financial Officer
|
Tel: +44 (0)1223 892 696 |
|
Nominated Adviser and Broker: Cavendish Capital Markets Ltd Matt Goode / Simon Hicks (Corporate Finance) Tim Redfern / Harriet Ward (ECM)
|
Tel: +44 (0) 20 7220 0500 |
|
Joint Broker: Canaccord Genuity Limited Simon Bridges / Andrew Potts
|
Tel: +44 (0) 20 7523 8000 |
|
Financial PR: Alma Strategic Communications Hilary Buchanan / Kieran Breheny |
Tel: +44 (0)20 3405 0205 |
About Nexteq
Nexteq (AIM: NXQ) is a strategic technology solutions provider to customers in selected industrial markets. Its innovative technology enables the manufacturers of global electronic equipment to outsource the design, development and supply of non-core aspects of their product offering. By outsourcing elements of their technology stack to Nexteq, customers can focus their product development effort on the most critical drivers of their business' success.
Our solutions are delivered through a global sales team and leverage the Group's electronic hardware, software, display and mechanical engineering expertise. Our Taiwan operation is at the heart of Asian supply networks and facilitates cost effective manufacturing and strategic supply chain management.
The Group operates in seven countries and services over 500 customers across 50 countries.
Nexteq operates two distinct brands: Quixant, a specialised computer platforms provider, and Densitron, leaders in human machine interface technology, each with dedicated sales, account management and product innovation teams. Founded in 2005, and later floating on the London Stock Exchange's AIM stock market as Quixant plc, the Group rebranded to Nexteq in 2023.
Further information on Nexteq and its divisions can be found at www.nexteqplc.com.
The notifications below are made in accordance with Article 19(3) of the Market Abuse Regulation:
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a) |
|
Johan Olivier |
|||
|
2 |
Reason for the notification
|
||||
|
a) |
Position/status |
Group Chief Financial Officer |
|||
|
b) |
Initial notification /Amendment |
Initial Notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a) |
Name |
Nexteq plc |
|||
|
b) |
LEI |
2138003VERSWQP561X71 |
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary shares of 0.1 pence each |
|||
|
|
|
||||
|
Identification code |
GB00B99PCP71 |
||||
|
|
|
||||
|
b) |
Nature of the transaction |
Exercise of options over Ordinary Shares Sale of Ordinary Shares |
|||
|
c) |
Price(s) and volume(s) |
|
|
|
|
|
|
|
Exercise of Options: |
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
0.1 pence |
25,000 |
|
|
|
|
|
Sale of Ordinary Shares: |
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
151 pence |
11,000 |
|
|
|
|
|
|
|
|
|
|
d) |
Aggregated information
Exercise of Options: |
|
|||
|
- Aggregated volume |
25,000 Ordinary Shares
|
||||
|
|
|
||||
|
- Price |
0.1 pence per Ordinary Share |
||||
|
Sale of Ordinary Shares: - Aggregated volume - Price |
11,000 Ordinary Shares 151 pence per Ordinary Share |
||||
|
e) |
Date of the transactions |
14 March 2024 |
|||
|
f) |
Place of the transaction |
London Stock Exchange |
|||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
